First Tracks Biotherapeutics Inc (TRAXV)

Apr 16, 2026

TRAXV|TRAXV.NB|Price:24.550| - TradingKey

Apr 16, 2026

Apr 15, 2026

First Tracks Biotherapeutics, Inc. (TRAXV) - Minichart

Apr 15, 2026

Apr 13, 2026

TRAXV Price Today: First Tracks Biotherapeutics, Inc. Stock Price, Quote & Chart | MEXC - MEXC

Apr 13, 2026

Apr 10, 2026

Anaptys to spin-off First Tracks Biotherapeutics, announces $100M buyback - MSN

Apr 10, 2026

Apr 07, 2026

TRAXV: Static price chart | First Tracks Biotherapeutics, Inc. | US3371851029 - marketscreener.com

Apr 07, 2026

Apr 07, 2026

First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (TRAXV) Stock Forecast & Price Prediction 2026–2030 - CoinCodex

Apr 07, 2026

Apr 06, 2026

Market Today: JPM's Dimon warns; UAL hikes fees; NBIX buys SLNO - GuruFocus

Apr 06, 2026

Apr 06, 2026

Spin-off Imminent At AnaptysBio - San Diego Business Journal

Apr 06, 2026

Apr 03, 2026

symbol__ Stock Quote Price and Forecast - CNN

Apr 03, 2026

Apr 03, 2026

First Tracks Biotherapeutics to be spun off from AnaptysBio, Nasdaq trading set for April 20 - Investing.com

Apr 03, 2026

Apr 01, 2026

ANAPTYSBIO (ANAB) reports ownership of 100 First Tracks Biotherapeutics shares - Stock Titan

Apr 01, 2026

Mar 30, 2026

First Tracks Biotherapeutics, the Planned Spin-Off of Anaptys, Secures Commitments of $145 Million in Private Placement - marketscreener.com

Mar 30, 2026

Mar 28, 2026

AnaptysBio authorizes $100M stock buyback, plans spin-off By Investing.com - Investing.com Australia

Mar 28, 2026

Mar 27, 2026

AnaptysBio appoints Susannah Gray to board; Dennis Mulroy and Eric Loumeau to Separate - TradingView — Track All Markets

Mar 27, 2026

Mar 27, 2026

Anaptys Announces $100 Million Stock Repurchase Plan and Provides a Business Update - Sahm

Mar 27, 2026

Mar 10, 2026

AnaptysBio Plans First Tracks Spin-Off as Jemperli Royalties Surge, Buybacks Possible - Yahoo Finance

Mar 10, 2026

Mar 06, 2026

Assessing AnaptysBio (ANAB) Valuation After Profitability Turnaround And Strong Jemperli Royalty Progress - Yahoo Finance

Mar 06, 2026

Mar 03, 2026

GSK's Biopharma Collaborations Highlighted in AnaptysBio Spin-Of - GuruFocus

Mar 03, 2026

Jul 29, 2025

Calidi Biotherapeutics Receives FDA Fast Track Designation for CLD-201 (SuperNova), a First-In-Class Stem-Cell Loaded Viral Therapy for the Treatment of Patients with Soft Tissue Sarcoma - Yahoo Finance

Jul 29, 2025

May 29, 2025

Press Release Service: Capsida Receives FDA Fast Track Designation for Its Potential First-in-Class IV-Administered Gene Therapy for STXBP1 Developmental and Epileptic Encephalopathy - CRISPR Medicine News

May 29, 2025

Feb 26, 2025

Fresh Tracks to cease stock trading as drug company dissolves - BizWest

Feb 26, 2025

Feb 25, 2025

Fresh Tracks Therapeutics Announces Dissolution, Initial Cash Distribution and Termination of Trading on the OTC Pink Market - Yahoo Finance

Feb 25, 2025

Nov 13, 2023

Fresh Tracks expects to distribute $5M to $7M to shareholders after dissolution - Daily Camera

Nov 13, 2023

Aug 14, 2023

Cash-strapped Fresh Tracks pauses R&D run as search for a buyer continues - Fierce Biotech

Aug 14, 2023

Jul 21, 2023

Fresh Tracks Announces $8.25 Million Buyout of Its Right to Receive Future Sofpironium Bromide Payments from Botanix - Yahoo Finance

Jul 21, 2023

Jul 20, 2023

Excision BioTherapeutics receives FDA Fast Track designation for EBT-101, a first-in-class CRISPR-based gene therapy candidate to functionally cure HIV-1 - European AIDS Treatment Group

Jul 20, 2023

Mar 08, 2023

Fresh Tracks may disappear as biotech mulls sale to continue autoimmune pipeline - Fierce Biotech

Mar 08, 2023

Sep 10, 2022

Fresh Tracks Therapeutics (FRTX) Stock Price, News & Analysis $FRTX - MarketBeat

Sep 10, 2022

Sep 07, 2022

Brickell Biotech Announces Corporate Rebranding to Fresh Tracks Therapeutics - GlobeNewswire

Sep 07, 2022